BlackRock Fund Advisors’s Intersect ENT, Inc XENT Stock Holding History

BlackRock Fund Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9.86M	Buy	814,609 +105,058	+15%	+$1.36M	﹤0.01%	2582
2016 Q3	$11.2M	Buy	709,551 +47,922	+7%	+$722K	﹤0.01%	2392
2016 Q2	$8.55M	Buy	661,629 +232,115	+54%	+$3.63M	﹤0.01%	2496
2016 Q1	$8.16M	Sell	429,514 -19,116	-4%	-$346K	﹤0.01%	2473
2015 Q4	$10.1M	Buy	448,630 +16,777	+4%	+$332K	﹤0.01%	2442
2015 Q3	$10.1M	Buy	431,853 +60,753	+16%	+$1.68M	﹤0.01%	2368
2015 Q2	$10.6M	Buy	371,100 +206,002	+125%	+$5.4M	﹤0.01%	2466
2015 Q1	$4.26M	Buy	165,098 +4,773	+3%	+$109K	﹤0.01%	2919
2014 Q4	$2.97M	Buy	160,325 +16,154	+11%	+$291K	﹤0.01%	3083
2014 Q3	$2.23M	Buy	+144,171	New	+$2.17M	﹤0.01%	3108

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock Fund Advisors's XENT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Intersect ENT, Inc (XENT) stake by 15% in Q4 2016, buying an estimated $1.36M and bringing the position to 814,609 shares worth $9.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2582.

BlackRock Fund Advisors first reported a position in XENT in Q3 2014 and has held it in 10 quarters since. The position peaked at $11.2M in Q3 2016. 104 funds tracked by Wall St. Rank hold XENT as of Q4 2016.

BlackRock Fund Advisors held 814,609 shares of Intersect ENT, Inc worth $9.86M as of Q4 2016.
BlackRock Fund Advisors bought 105,058 Intersect ENT, Inc shares in Q4 2016, an estimated $1.36M.
Intersect ENT, Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2582 holding.
BlackRock Fund Advisors first reported a position in Intersect ENT, Inc in Q3 2014 and has held it in 10 quarters since.
BlackRock Fund Advisors's Intersect ENT, Inc position peaked at $11.2M in Q3 2016.
104 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.